Manuscript
Type 2 diabetes risk alleles in peptidyl-glycine alpha-amidating monooxygenase influence GLP-1 levels and response to GLP-1 receptor agonists
Mahesh M Umapathysivam et al.
Genome Med. 2026
Manuscript
Worsening Kidney Function and Cardiovascular Outcomes in Type 2 Diabetes and Atherosclerotic Disease
Abhinav Sharma et al.
JACC Adv. 2026;5:102598
Manuscript
Validation of an algorithm for selection of SGLT2 and DPP4 inhibitor therapies in people with type 2 diabetes across major UK ethnicity groups: a retrospective cohort study
Laura M. Güdemann et al.
The Lancet Regional Health – Europe 2026;61:101547
Manuscript
Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS Outcomes Model using TECOS and EXSCEL data
Coleman RL et al.
Diabetes Obes Metab. 2026;28:1068-1075
Manuscript
The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review
Ashni Goshrani et al.
Diabetes Care 2026;49:197-210
Manuscript
Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy
Eberhard Standl et al.
Cardiovasc Diabetol. 2025;14:441